Ovariyektomi Sonrası Meydana Gelen Osteoporoz ve Uygulanan Tedaviler Sonras›nda Sıçan Tiroidi Parafoliküler Hücrelerdeki Morfolojik Değişiklikler

___

  • 1. Chambers TJ, Azria M. The effect of calcitonin on the osteoclast. Triangle 1988; 27: 53-60.
  • 2. Delmas PD. Biochemical markers of bone turnover methodology and clinical use in osteoporosis. Am J Med 1991; 91: 595-635.
  • 3. Dick IM, John A St, Heal S, Prince RL. The effect of estrogen deficiency on bone mineral density, renal calcium and phosphorus handling and calcitropic hormones in the rat. Calcif Tissue Int 1996; 59: 174-178.
  • 4. Farley JR, Tarbaux NM, Hall SL, Linkhart TA, Bayling DJ. The anti-bone. Resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation. Endocrinology 1988; 123: 159-167.
  • 5. Filipovic B, Sosic-Jurjevic B, Manojlovic Stojanoski M, Nestorovic N, Milosevic V, Sekulic M. The effect of ovariectomy on thyroid C cells of adult rats. Yugoslavian Medical Biochemistry 2002; 21: 345- 350.
  • 6. Filipovic B, Sosic-Jurjevic B, Nestorovic N, et al. The thyroid C cells of ovariectomized rats treated with estradiol. Histochem Cell Biol 2003; 120: 409-414.
  • 7. Ito MB, Schraer H, Gay CV. The effects of calcitonin, parathyroid hormone and prostaglandin E2 on cylic AMP levels of isolated osteoclasts. Comp Biochem Physiol A Comp Physiol 1985; 81: 653-657.
  • 8. Judd HL, Shanonki IM, Frumar AM, Lagasse LD. Origin of serum estradiol in postmenopausal women. Obstet Gynecol 1982; 59: 680-686.
  • 9. Lindsay R. The menopause and osteoporosis. Obstet Gynecol 1996; 87: 165-195.
  • 10. Nicholson GC, Moseley JM, Sexton P, Mendelsohn FA, Martin TJ. Abundant calcitonin receptors in rat osteoclast: autoradiographic and biochemical characterisation. J Clin Invest 1986; 78: 355-360.
  • 11. Nilas L, Christiansen C. Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab 1987; 65: 697.
  • 12. Pacifici R, Vannice JL, Rifas L, Kimble RB. Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab 1993; 77: 1135-1141.
  • 13. Peng Z, Tuukkanen J, Zhang H, Jämsä T, Väänänen HK. The mechanical strength of bone in different rat models of experimental dsteoporosis. Bone 1994; 15: 523-525.
  • 14. Sakai K, Yamada S, Yamada K. Effects of ovariectomy on parafollicular cells in the rats. Okajimas Folia Anat Jpn 2000; 7: 311-319.
  • 15. Shamonki IM, Frumar AM, Tataryn IV, et al. Age related changes of calcitonin secretion in females. J Clin Endocrinol Metab 1980; 50: 437-439.
  • 16. Simon LS. Osteoporosis. Clin Geriatr Med 2005; 21: 603-629.
  • 17. Teitelbaum SL, Rosenberg EM, Richardson CA, Avioli LV. Histological studies of bone from normocalcemic postmenopausal dsteoporotic patient with increased circulating parathyroid hormone. J Clin Endocrinol Metab 1976; 42: 537-543.
  • 18. Teitelbaum SL, Tondravi MM, Ross FP. Osteoclast macrophages and the molecular mechanisms of bone resorption. J Leukocyte Biology 1997; 61: 381-388.
  • 19. Vaes G. Cellular biology and biochemical mechanism of bone resorption. Clin Orthop Rel Res 1988; 231: 239-271.